Alnylam Pharmaceuticals
ALNY
#643
Rank
A$55.40 B
Marketcap
A$415.00
Share price
-1.02%
Change (1 day)
-7.29%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company